Gilbert Block

3.5k total citations · 1 hit paper
30 papers, 2.6k citations indexed

About

Gilbert Block is a scholar working on Psychiatry and Mental health, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Gilbert Block has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Surgery and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Gilbert Block's work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Gilbert Block is often cited by papers focused on Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Gilbert Block collaborates with scholars based in United States, United Kingdom and Denmark. Gilbert Block's co-authors include Scott A. Reines, Christopher R. Lines, Michael L. Nessly, Christine Baranak, Peer Tfelt‐Hansen, Michel D. Ferrari, Vincenzo Guidetti, TJ Steiner, Peter J. Goadsby and RB Lipton and has published in prestigious journals such as Neurology, The Lancet Neurology and Brain Research.

In The Last Decade

Gilbert Block

28 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

2000 549 citations Peer Tfelt‐Hansen, Gilbert Block et al. Cephalalgia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilbert Block United States	22	1.3k	970	713	306	305	30	2.6k
Virgilio Gallai Italy	40	1.8k 1.4×	1.3k 1.4×	1.2k 1.7×	379 1.2×	644 2.1×	132	4.7k
Neil H. Raskin United States	26	1.3k 1.0×	689 0.7×	940 1.3×	469 1.5×	515 1.7×	51	2.4k
Mark W. J. Strachan United Kingdom	40	761 0.6×	1.2k 1.2×	185 0.3×	770 2.5×	173 0.6×	146	5.8k
Toshifumi Matsui Japan	31	721 0.6×	1.5k 1.5×	431 0.6×	238 0.8×	357 1.2×	102	3.4k
Yili Pritchett United States	34	805 0.6×	1.3k 1.4×	395 0.6×	246 0.8×	1.1k 3.6×	57	4.4k
Ling Zheng United States	25	922 0.7×	575 0.6×	260 0.4×	93 0.3×	346 1.1×	54	2.4k
Lena Kilander Sweden	31	1.4k 1.1×	1.3k 1.3×	131 0.2×	107 0.3×	386 1.3×	70	3.6k
Péter Sándor Switzerland	26	2.2k 1.7×	1.0k 1.1×	1.2k 1.6×	193 0.6×	315 1.0×	110	3.4k
Christian Lampl Austria	26	2.4k 1.9×	857 0.9×	1.4k 1.9×	265 0.9×	444 1.5×	69	3.0k
Tomio Okamura Japan	33	306 0.2×	2.1k 2.2×	233 0.3×	472 1.5×	269 0.9×	167	4.1k

Countries citing papers authored by Gilbert Block

Since Specialization

Citations

This map shows the geographic impact of Gilbert Block's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert Block with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert Block more than expected).

Fields of papers citing papers by Gilbert Block

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert Block. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert Block. The network helps show where Gilbert Block may publish in the future.

Co-authorship network of co-authors of Gilbert Block

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert Block. A scholar is included among the top collaborators of Gilbert Block based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert Block. Gilbert Block is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maynard, George, R. Kannan, Jian Liu, et al.. (2023). Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial. The Lancet Neurology. 22(8). 672–684. 29 indexed citations

Miller, Robert, et al.. (2018). Randomized Phase 2B trial of NP001, a Novel Immune Regulator, in ALS (S38.004). Neurology. 90(15_supplement). 1 indexed citations

Duchâteau-Nguyen, Guillemette, et al.. (2014). Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clinical Kidney Journal. 7(2). 167–173. 46 indexed citations

Delmez, James A., Gilbert Block, John A. Robertson, et al.. (2007). A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clinical Nephrology. 68(12). 386–391. 74 indexed citations

Thal, Leon J., Steven H. Ferris, Louis Kirby, et al.. (2005). A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment. Neuropsychopharmacology. 30(6). 1204–1215. 307 indexed citations

Reines, S., Gilbert Block, John C. Morris, et al.. (2004). Rofecoxib. Neurology. 62(1). 66–71. 285 indexed citations

Lines, Christopher R., Kathleen McCarroll, Richard B. Lipton, & Gilbert Block. (2003). Telephone screening for amnestic mild cognitive impairment. Neurology. 60(2). 261–266. 78 indexed citations

Tfelt‐Hansen, Peer, Gilbert Block, C Dahlöf, et al.. (2000). Guidelines for Controlled Trials of Drugs in Migraine: Second Edition. Cephalalgia. 20(9). 765–786. 549 indexed citations breakdown →

Goldstein, Jerome, Robert Ryan, Kaihong Jiang, et al.. (1998). Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in Migraine. Headache The Journal of Head and Face Pain. 38(10). 737–747. 137 indexed citations

10.

Tfelt‐Hansen, Peer, Francisco Javier Rodríguez‐Gómez, Mario Giacovazzo, et al.. (1998). Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine. Headache The Journal of Head and Face Pain. 38(10). 748–755. 158 indexed citations

11.

Tuchman, Michael, Neal R. Cutler, Michael L. Gross, et al.. (1998). Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient Study. Headache The Journal of Head and Face Pain. 38(4). 281–287. 116 indexed citations

12.

Block, Gilbert, Jerome Goldstein, Adam B. Polis, Scott A. Reines, & Mary E. Smith. (1998). Efficacy and Safety of Rizatriptan Versus Standard Care During Long‐term Treatment for Migraine. Headache The Journal of Head and Face Pain. 38(10). 764–771. 52 indexed citations

13.

Block, Gilbert, Charles Liss, Scott A. Reines, Joseph Irr, & Donald W. Nibbelink. (1997). Comparison of Immediate-Release and Controlled Release Carbidopa/Levodopa in Parkinson’s Disease. European Neurology. 37(1). 23–27. 175 indexed citations

14.

Liss, Charles, et al.. (1997). CR FIRST. Clinical Drug Investigation. 13(1). 15–22. 1 indexed citations

15.

Cutler, Neal R., James L. Claghorn, Gilbert Block, et al.. (1996). MK-462 in migraine: A pilot study.. Clinical Pharmacology & Therapeutics. 59(2). 196–196.

16.

Gengo, Fran M., et al.. (1995). Effects of treatment with lovastatin and pravastatin on daytime cognitive performance. Clinical Cardiology. 18(4). 209–214. 53 indexed citations

17.

Block, Gilbert, et al.. (1994). A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase. Life Sciences. 56(5). 319–326. 24 indexed citations

18.

Partinen, Markku, et al.. (1994). Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia. The American Journal of Cardiology. 73(12). 876–880. 21 indexed citations

19.

Hammerstad, John P., et al.. (1994). Controlled Release Levodopa/Carbidopa 25/100 (Sinemet CR 25/100). Clinical Neuropharmacology. 17(5). 429–434. 15 indexed citations

20.

Olanow, C. Warren, Paul A. Nausieda, B. V. Manyam, et al.. (1991). An Open Multicenter Trial of Sinemet CR in Levodopa-Naive Parkinsonʼs Disease Patients. Clinical Neuropharmacology. 14(3). 235–240. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact